26 June 2020

2019: Building on Success and Launching New Initiatives

Oncode Institute is proud to present the public summary of its second Annual Report.

Vesna de Jong

Vesna de Jong

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.

The report showcases the highlights of Oncode in 2019. Outsmarting cancer is one of the most ambitious missions of our times - one that no single group can complete on its own. That’s why we have joined the forces of 61 research groups across the Netherlands. Our 800+ researchers have access to world class infrastructure, technologies, training, support teams and financial means to support high-risk research projects. Oncode’s scientific community is deliberately set up to promote interdisciplinary research, reduce barriers to collaboration, and foster a culture of openness and sharing.

We invite you to read about how we did that last year and what we are planning for the future.

Click here to read the full report

Other News

Picture1
Absence of stem cells in pancreas changes view on pancreatic cancer
New research by Oncode Investigator Louis Vermeulen and co-investigator Maarten Bijlsma shows that there are no stem cells in the pancreas. These unexpected findings potentially have major implications for pancreatic cancer research, since stem cells are often at the root of tumor development. This research was published today in the leading journal Cell Stem Cell.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Support Programme
Antibodies with a mission: what the Utrecht Monoclonal Antibody Facility (UMab) can do for you
As part of the Infrastructure and Technology programme, Oncode started a collaborative project together with Oncode Investigator Linde Meyaard (UMCU) and Jeanette Leusen (head of the Utrecht Monoclonal Antibody Facility (UMab)) with the goal of being able to offer Oncode Investigators the opportunity to produce high quality antibodies (targeted against membrane proteins). Oncode is now looking to fund a total of 4 Oncode Investigators to develop monoclonal antibodies potentially suited for clinical applications in oncology, directed against their membrane target of choice.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Oncode Icons Square research strategy copy
Oncode collaboration results in a new mathematical method that can predict cancer survival based on genetic changes
As cancer survival rates vary widely, Oncode Researcher Daniel Miedema from Oncode Investigator Louis Vermeulen’s lab (Amsterdam UMC), in collaboration with the teams of Oncode Investigators Hugo Snippert (UMC Utrecht) and Geert Kops (Hubrecht Institute) has developed a mathematical method to predict survival based on genetic changes in cancer. The results of this study are now published in Nature Communications.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>